Tokyo, Japan

Yoshiya Amemiya


Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 1989-2008

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yoshiya Amemiya: Innovator in Pharmaceutical Chemistry

Introduction

Yoshiya Amemiya is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of six patents to his name, Amemiya's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents is a phenylene derivative featuring a tetrazole ring or thiazolidinedione ring. This invention provides a compound represented by a specific formula, where A is a cyclic group, B is a 1H-tetrazol-5-yl group or a 2,4-dioxothiazolidin-5-yl group, and Y is a single bond or a C6-10 arylene group, along with its pharmacologically acceptable salts or esters. Another notable patent involves angiotensin II antagonist 1-biphenylmethylimidazole compounds. This compound has hypotensive activity and can be utilized for the treatment and prevention of hypertension.

Career Highlights

Yoshiya Amemiya has worked with notable companies such as Sankyo Company, Limited and Renascience Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Amemiya has collaborated with esteemed colleagues, including Hiroaki Yanagisawa and Yasuo Shimoji. These partnerships have contributed to the advancement of his research and the successful development of innovative compounds.

Conclusion

Yoshiya Amemiya's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…